Institution
Praxis
Nonprofit•Tallinn, Estonia•
About: Praxis is a nonprofit organization based out in Tallinn, Estonia. It is known for research contribution in the topics: Population & Medicine. The organization has 5311 authors who have published 6645 publications receiving 105752 citations.
Topics: Population, Medicine, Cancer, Breast cancer, Randomized controlled trial
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The study indicates that, in terms of infections, baby swimming might not be as harmless as commonly thought, and further evidence is needed to make conclusions if the current regulations on chlorine in Germany might not protect swimming pool attendees from an increased risk of gastrointestinal infections.
83 citations
••
TL;DR: The data show that de novo VEGFR3 mutations may be present in patients without family history of congenital lymphedema, and VEG FR3 screening should be added to the investigation of cases of hydrops fetalis of an unknown etiology.
Abstract: Mutations in the vascular endothelial growth factor receptor 3 gene, VEGFR3/FLT4, have been identified in a subset of families with hereditary lymphedema type I or Milroy disease (MIM 153100). Individuals carrying a VEGFR3 mutation exhibit congenital edema of the lower limbs, usually bilaterally and below the knees, sometimes associated with cellulitis, prominent veins, papillomatosis, upturned toenails, and hydrocele. In this study, we report the first de novo VEGFR3 mutation in a patient with sporadic congenital lymphedema. We also describe three other families with a VEGFR3 mutation. In each family, one individual had an atypical clinical presentation of hereditary lymphedema type I, whereas the others had the classical VEGFR3 mutation-caused phenotype. The atypical presentations included pre-natal pleural effusion, spontaneous resorption of lymphedema and elephantiasis. Three of the four identified mutations were novel. These data show that de novo VEGFR3 mutations may be present in patients without family history of congenital lymphedema. This has implications for follow-up care, as such individuals have nearly a 50% risk for occurrence of lymphedema in their children. Our findings also indicate that although most patients with a VEGFR3 mutation have the well-defined phenotype for hereditary lymphedema type I, there are exceptions that should be considered in genetic counseling. Because VEGFR3 mutation can cause generalized lymphatic dysfunction and can thus result in hydrops fetalis, VEGFR3 screening should be added to the investigation of cases of hydrops fetalis of an unknown etiology.
83 citations
•
02 Jul 2004TL;DR: In this paper, the porosity is provided by the use of an extractable particulate in a powder forming route to create a desired porosity, which minimizes contamination of the sintered article and allows for the processing of material sensitive to contamination such as titanium.
Abstract: A porous metal article having a predetermined pore structure. The porosity is provided by the use of an extractable particulate in a powder forming route to create a desired porosity. Extraction of the pore forming particulate prior to sintering of the powder minimizes contamination of the sintered article and allows for the processing of material sensitive to contamination such as titanium. Added functionality can be gained by co-forming the porous material with non-porous material to create an article with layers of differing characteristics. The article is suitable for use as an implant body is porous enough to facilitate tissue in-growth and bony fusion.
83 citations
••
TL;DR: A large, multi‐national, observational study assessing the safety and efficacy of insulin detemir reports the study design, population characteristics and baseline observations, including cross‐sectional analysis, from 19 911 patients with type 1 or 2 diabetes.
Abstract: Aim: PREDICTIVE™ (Predictable Results and Experience in Diabetes through Intensification and Control to Target: An International Variability Evaluation) is a large, multi-national, observational study assessing the safety and efficacy of insulin detemir. We report the study design, population characteristics and baseline observations, including cross-sectional analysis, from 19 911 patients with type 1 or 2 diabetes.
Methods: Patients with type 1 or 2 diabetes requiring basal insulin are prescribed insulin detemir and followed up for 12–52 weeks. Data on demographics, haemoglobin A1c (HbA1c), fasting glucose, within-subject fasting glucose variability and weight are collected from patient records (and/or recall for hypoglycaemia). A negative binomial distribution model is used to assess the influence of predictive/confounding variables on hypoglycaemic episodes in insulin-treated patients at baseline. Multi-factorial analysis of covariance is used to evaluate the association of the variables with current body weight and within-subject fasting glucose variability.
Results: Total hypoglycaemic episodes in the 4 weeks prior to study start were 47.5 per patient-year in patients with type 1 and 9.2 per patient-year in patients with type 2 diabetes. The frequency of hypoglycaemia in insulin-treated patients showed a significant, positive association with duration of diabetes, number of insulin injections and fasting glucose variability but was inversely related to HbA1c, fasting glucose and body mass index. Weight showed a significant positive association with gender (male > female) and insulin dosage. Weight was also positively associated with fasting glucose variability in patients with type 1 diabetes, and age and number of injections in patients with type 2 diabetes.
Conclusions: These baseline data showed that, in addition to the established relationship with intensive treatment and HbA1c, frequency of hypoglycaemia was positively associated with fasting glucose variability. Follow-up data from PREDICTIVE will provide insights on insulin detemir in diabetes management.
83 citations
••
TL;DR: Prejudice about the possible occurrence, i.e. the Hawthorne effect, of ED with METO facilitates the occurrence of this side effect in hypertensive men, and it is not surprising that placebo is as effective as tadalafil in reversing this sideeffect.
Abstract: Aims: It is often assumed that β-blockers, e.g. metoprolol (METO), induce erectile dysfunction (ED) in men. However, cardiovascular diseases can also induce ED and there is also the
83 citations
Authors
Showing all 5347 results
Name | H-index | Papers | Citations |
---|---|---|---|
Dirk Schadendorf | 127 | 1017 | 105777 |
Tobias Banaschewski | 85 | 692 | 31686 |
Jörg Neugebauer | 81 | 491 | 30909 |
K. S. Wood | 78 | 221 | 23565 |
Dirk J. Ruiter | 77 | 301 | 18589 |
Christoph Loddenkemper | 70 | 269 | 17416 |
Andreas Kupsch | 69 | 238 | 18846 |
Paulo J. Oliveira | 66 | 530 | 18361 |
Andreas Schober | 64 | 345 | 16791 |
Witold Rużyłło | 63 | 356 | 30286 |
Marcus Quinkler | 62 | 264 | 12284 |
Valentino J. Stella | 59 | 287 | 14084 |
Peter M. Villiger | 58 | 240 | 11487 |
Nadim Joni Shah | 57 | 220 | 11152 |
Steven Petrou | 56 | 231 | 11140 |